Bio-Techne (TECH) EBT Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.45% |
| Dec 31, 2025 | -2.06% |
| Sep 30, 2025 | 4.06% |
| Jun 30, 2025 | -30.48% |
| Mar 31, 2025 | -3.95% |
| Dec 31, 2024 | -22.19% |
| Sep 30, 2024 | 17.67% |
| Jun 30, 2024 | 6.20% |
| Mar 31, 2024 | 4.14% |
| Dec 31, 2023 | 8.93% |
| Sep 30, 2023 | 23.02% |
| Jun 30, 2023 | 40.59% |
| Mar 31, 2023 | 26.27% |
| Dec 31, 2022 | 25.04% |
| Sep 30, 2022 | 35.19% |
| Jun 30, 2022 | 15.87% |
| Mar 31, 2022 | 17.17% |
| Dec 31, 2021 | 41.51% |
| Sep 30, 2021 | 19.38% |
| Jun 30, 2021 | -44.72% |
| Mar 31, 2021 | 1.31% |
| Dec 31, 2020 | 9.77% |
| Sep 30, 2020 | 4.32% |
| Jun 30, 2020 | 60.12% |
| Mar 31, 2020 | 3.85% |
| Dec 31, 2019 | 28.71% |
| Sep 30, 2019 | -12.44% |
| Jun 30, 2019 | 17.69% |
| Mar 31, 2019 | 1.60% |
| Dec 31, 2018 | -9.68% |
| Sep 30, 2018 | -15.01% |
| Jun 30, 2018 | -21.25% |
| Mar 31, 2018 | -10.89% |
| Dec 31, 2017 | -10.31% |
| Sep 30, 2017 | -9.57% |
| Jun 30, 2017 | -1.40% |
| Mar 31, 2017 | -6.34% |
| Dec 31, 2016 | -16.70% |
| Sep 30, 2016 | -7.26% |
| Jun 30, 2016 | 16.20% |
| Mar 31, 2016 | -1.31% |
| Dec 31, 2015 | -1.25% |
| Sep 30, 2015 | -3.95% |
| Jun 30, 2015 | 15.64% |
| Mar 31, 2015 | -1.33% |
| Dec 31, 2014 | 3.01% |
| Sep 30, 2014 | -2.72% |